PTC Therapeutics faces significant risks with its key revenue sources, Translarna and Emflaza. Find out why I am sticking ...

The Global Equity ADR composite rose 5.3% gross of fees in the third quarter of 2024, trailing the 6.7% gain in the MSCI ACWI Index. Click here to read the full commentary.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...